A voluntary organisation providing assistance to individuals diagnosed with breast cancer is warning that one of its flagship occasions may not take place unless additional participants come forward.
Bosom Friends Bradford operates as an independent, patient-led charitable group offering support to those whose lives have been affected by breast cancer.
The group is seeking volunteers to get involved in its upcoming runway presentation, which has been designed to highlight the strength and determination of people navigating life after a cancer diagnosis.
The event is scheduled for late October at a secondary school in the city.
The group is extending an open invitation to people from all walks of life who have received a breast cancer diagnosis, regardless of gender.
Individuals who are currently undergoing treatment, have recently been diagnosed, or who completed their recovery years ago are all eligible to participate.
Previous modelling work is not a requirement for involvement.
The initiative represents more than just an opportunity to display clothing.
According to the organisation, the occasion provides a platform for participants to demonstrate bravery, foster community connections, and display what genuine resilience resembles.
Bosom Friends Bradford was established with the aim of tackling loneliness and delivering both practical assistance and opportunities for social interaction.
The group coordinates meetups, raises funds through various activities, and stages events in collaboration with the local NHS breast care team.
The stated mission of the charity centers on creating a welcoming space where individuals can form connections and discuss their personal journeys.
Those wishing to get involved with the fashion show can reach out through the organisation’s social media presence or contact two designated representatives by telephone using the numbers provided.
The charity holds official registration with the Charity Commission and functions independently to provide companionship and aid to anyone impacted by breast cancer.